---
figid: PMC11967956__pone.0303736.g007
figtitle: Summary scheme of the obtained data
organisms:
- NA
organisms_ner:
- Danio rerio
- Homo sapiens
pmcid: PMC11967956
filename: pone.0303736.g007.jpg
figlink: /pmc/articles/PMC11967956/figure/F7/
number: F7
caption: 'In silico analysis of phytochemicals from the herbal plant H. alpestre,
  identified using LC-HRMS/MS, highlighted Chrysoeriol glucuronide and Pseudohypericin
  as the most active compounds. Experimental validation using WB, ELISA, and chromatin
  staining demonstrated that the combined treatment with the plant extract and the
  L-arginine metabolic pathway inhibitor L-NAME effectively inhibited the PI3K/Akt
  signaling pathway. This inhibition resulted in upregulated expression of P53 and
  Caspase-3. PI3K: Phosphoinositide 3-kinase; Akt: Protein Kinase B; TNFa: Tumor Necrosis
  Factor-alpha; VEGFa: Vascular Endothelial Growth Factor-alpha; TNFR: Tumor Necrosis
  Factor Receptor; VEGFR: Vascular Endothelial Growth Factor Receptor; L-NAME: Nω-Nitro-L-arginine
  methyl ester (an inhibitor of nitric oxide synthase); mTOR: Mammalian Target of
  Rapamycin; P53: Tumor Suppressor Protein 53; MMP-2: Matrix Metalloproteinase-2;
  COX-2: Cyclooxygenase-2; LC-HRMS/MS: Liquid Chromatography-High-Resolution Mass
  Spectrometry'
papertitle: Elucidating the impact of Hypericum alpestre extract and L-NAME on the
  PI3K/Akt signaling pathway in A549 lung adenocarcinoma and MDA-MB-231 triple-negative
  breast cancer cells
reftext: Hayarpi Javrushyan, et al. PLoS One. 2025;20(4).
year: '2025'
doi: 10.1371/journal.pone.0303736
journal_title: PLOS One
journal_nlm_ta: PLoS One
publisher_name: PLOS
keywords: ''
automl_pathway: 0.9300837
figid_alias: PMC11967956__F7
figtype: Figure
redirect_from: /figures/PMC11967956__F7
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC11967956__pone.0303736.g007.html
  '@type': Dataset
  description: 'In silico analysis of phytochemicals from the herbal plant H. alpestre,
    identified using LC-HRMS/MS, highlighted Chrysoeriol glucuronide and Pseudohypericin
    as the most active compounds. Experimental validation using WB, ELISA, and chromatin
    staining demonstrated that the combined treatment with the plant extract and the
    L-arginine metabolic pathway inhibitor L-NAME effectively inhibited the PI3K/Akt
    signaling pathway. This inhibition resulted in upregulated expression of P53 and
    Caspase-3. PI3K: Phosphoinositide 3-kinase; Akt: Protein Kinase B; TNFa: Tumor
    Necrosis Factor-alpha; VEGFa: Vascular Endothelial Growth Factor-alpha; TNFR:
    Tumor Necrosis Factor Receptor; VEGFR: Vascular Endothelial Growth Factor Receptor;
    L-NAME: Nω-Nitro-L-arginine methyl ester (an inhibitor of nitric oxide synthase);
    mTOR: Mammalian Target of Rapamycin; P53: Tumor Suppressor Protein 53; MMP-2:
    Matrix Metalloproteinase-2; COX-2: Cyclooxygenase-2; LC-HRMS/MS: Liquid Chromatography-High-Resolution
    Mass Spectrometry'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - tnfa
  - tnfb
  - vegfaa
  - mmp2
  - COX2
  - mtor
  - tp53
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - AKT1
  - AKT2
  - AKT3
  - TNF
  - VEGFA
  - TNFRSF1A
  - KDR
  - FLT1
  - FLT4
  - MMP2
  - MS
  - PTGS2
  - MTOR
  - TP53
  - TP63
  - TP73
  - L-NAME
  - cancer
---
